Objective. The aim of this study was to compare the immunohistochemical expression of nuclear factor B (NF-B), matrix metalloproteinase 9 (MMP-9), and CD105 in odontogenic keratocysts (OKCs), dentigerous cysts (DCs), and radicular cysts (RCs). Study design. Twenty cases of OKCs, 20 DCs, and 20 RCs were analyzed. A labeling index (LI), which expresses the percentage of NF-B-stained nuclei, was calculated for the analysis of NF-B expression. Expression of MMP-9 in the epithelium and in the capsule of each lesion was scored as 0 (Ͻ10% stained cells), 1 (10%-50% stained cells), or 2 (Ͼ50% stained cells). In addition, MMP-9 immunostaining was analyzed in endothelial cells of vessels with a conspicuous lumen. The angiogenic index was determined based on the number of anti-CD105 antibody-stained microvessels.
Odontogenic cysts comprise a group of osseodestructive lesions that frequently affect the jaws. These cysts can arise from epithelial components of the tooth germ, the reduced epithelium of the enamel organ, epithelial rests of Malassez, remnants of dental lamina, or the basal layer of the oral epithelium. 1, 2 The odontogenic keratocyst (OKC), recently reclassified by the World Health Organization as a keratocystic odontogenic tumor, 3 is a developmental cyst characterized by an aggressive nature and high rate of recurrence, especially compared with other odontogenic cysts. 4 The dentigerous cyst (DC) is the most common developmental odontogenic cyst and usually associated with the crowns of impacted permanent teeth. This cyst shows an indolent behavior, and recurrence is rare after removal. 2, 4, 5 The radicular cyst (RC) is an odontogenic cyst of inflammatory origin that arises from the inflammatory stimulation of the epithelial rests of Malassez. 6, 7 RCs, DCs, and OKCs show distinct growth patterns and biologic behaviors. Previous studies have investigated transcription factors and factors related to tissue remodeling and angiogenesis which might be associated with the development of these lesions in an attempt to determine which factors that may be responsible for the specific biologic behavior of each type of lesion.
Nuclear factor B (NF-B) belongs to a family of transcription factors 8 that regulates the expression of various genes, including matrix metalloproteinase 9 (MMP-9) and vascular endothelial growth factor genes whose products are involved in tumorigenesis. 9 However, little is known about the role of NF-B in odontogenic lesions. 10 MMPs comprise a family of calcium-and zinc-dependent enzymes that are able to degrade extracellular matrix components under both physiologic and pathologic conditions. [11] [12] [13] Studies suggest that enzymatic degradation of the bone matrix and basement membrane by MMP-9 and other metalloproteinases is involved in the expansion of odontogenic cysts. [14] [15] [16] Endoglin, also known as CD105, is a transmembrane protein that is highly expressed on human vascular endothelial cells. 17 Unlike panendothelial antibodies, such as CD31, CD34, and factor VIII, endoglin is able to distinguish endothelial cells proliferating from preexisting blood vessels. Several studies emphasize the involvement of CD105 in blood vessel formation and that its utility as a powerful marker for the quantification of microvessels in many types of tumors. 18 In view of the distinct clinical behaviors of OKCs, RCs, and DCs the objective of the present investigation was to compare the immunohistochemical expression of NF-B, MMP-9, and endoglin between these lesions.
MATERIALS AND METHODS
Twenty cases each of OKC, DC, and RC were studied. Formalin (10%)-fixed and paraffin-embedded specimens were selected among cases diagnosed and archived at the Pathologic Anatomy Service of the Discipline of Oral Pathology, Department of Dentistry, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil. The study was approved by the Ethics Committee of UFRN (protocol no. 094/09).
Immunohistochemical method
Paraffin-embedded material was cut into 3-m-thick sections and the specimens mounted on glass slides prepared with organosilane coupling agent (3-aminopropyltriethoxysilane; Sigma Chemical Co., St. Louis, MO, USA). The tissue sections were deparaffinized, submitted to antigen retrieval with citrate (pH 6.0) in a Pascal pressure cooker (Dako, Carpinteria, CA, USA), and then immersed in 10 volumes of hydrogen peroxide to block endogenous peroxidase activity. Next, the sections were washed in phosphate-buffered saline solution (PBS). After treatment with normal serum, the sections were incubated with the following primary antibodies in a moist chamber: anti-NF-B (clone sc-109; Santa Cruz Biotechnology, Santa Cruz, CA, USA; dilution 1:100, 180 minutes), anti-MMP-9 (clone 2C3; NovoCastra, Newcastle upon Tyne, U.K.; dilution 1:80, overnight), and anti-CD105 (clone SN6h; Dako; dilution 1:500, overnight). The sections were washed twice in PBS and incubated with the labeled streptavidin- biotin complex (Dako) at room temperature. Peroxidase activity was developed by immersion of the sections in diaminobenzidine (D5637; Sigma Chemical Co.). Finally, the sections were counterstained with Mayer hematoxylin, covered with a glass coverslip, and mounted in Permount (SP15-500; Fisher Scientific, Fair Lawn, NJ, USA).
Prostate carcinoma and kidney and liver fragments were used as positive control samples for NF-B, MMP-9, and CD105, respectively. The negative control involved substitution of the primary antibody with 1% bovine serum albumin in PBS.
Analysis of the immunohistochemical profile
The slides were examined under a light microscope (Olympus Cx31; Tokyo, Japan) at ϫ400 magnification. NF-B staining was analyzed by an adaptation of the method proposed by Nakayama et al. 19 For this purpose, 1,000 epithelial cells were counted in 5 different representative fields of the cystic lesions. A labeling index (LI), which expresses the percentage of NF-Bimmunostained nuclei, was calculated based on the number of immunopositive nuclei. MMP-9 staining was evaluated according to Gong et al., 10 with some modifications. Ten histologic fields each were selected in the epithelial component and in the connective tissue capsule. Immunoexpression of MMP-9 was scored in each case as 0 (Ͻ10% immunostained cells), 1 (10%-50% immunostained cells), or 2 (Ͼ50% immunostained cells). In addition, expression of MMP-9 was analyzed in endothelial cells of vessels with a conspicuous lumen at ϫ400 magnification, selecting 5 fields that showed the highest immunoreactivity.
The angiogenic index of OKCs, DCs, and RCs was determined by the quantification of anti-CD105-immunoreactive vessels by an adaptation of the method of Maeda et al. 20 Ten areas of highest anti-CD105 immunoreactivity were identified at 40ϫ magnification and the microvessel count (MVC) was obtained by counting immunostained vessels in these areas at 200ϫ magnification.
Statistical analysis
The results were analyzed with the use of the Statistical Package for the Social Sciences (version 17.0; SPSS, Chicago, IL, USA). NF-B LIs in the epithelium were compared between the different cysts by the nonparametric Kruskal-Wallis test. For the analysis of MMP-9 expression, scores 0 and 1 were combined into one group and score 2 remained as another group. Differences in MMP-9 expression in the cystic epithelium and in the connective tissue capsule were evaluated by the 2 test. Differences between NF-B LIs according to MMP-9 expression in the cystic epithelium were evaluated by the nonparametric Mann-Whitney test. The Kruskal-Wallis test was used for the comparison of the number of CD105-immunostained blood vessels. Possible differences in MVC according to the expression of MMP-9 in the vessels of odontogenic cysts were evaluated by the nonparametric MannWhitney test. A level of significance of 5% (P Ͻ .05) was established for all tests.
RESULTS
The mean NF-B LI in the epithelial lining was higher in OKCs (21.1%, range 3.7%-44.2%) than in DCs (8.7%, range 0.2%-31.6%) and RCs (1.4%, range 0.2%-5.5%; Fig. 1 ). Nonparametric tests revealed significant difference between groups (P Ͻ .001; Table I ).
Regarding the epithelial expression of MMP-9, there was a predominance of score 2 (n ϭ 18; 90%) in OKCs, whereas score 1 was predominantly observed in the other 2 cases (10%). Similarly, score 2 predominated in DCs (n ϭ 14; 70%), but the distribution of scores 0 (n ϭ 4; 20%) and score 1 (n ϭ 2; 10%) was relatively similar. In RCs, most cases were classified as score 2 (n ϭ 13; 65%), followed by score 1 (n ϭ 5; 25%) and score 0 (n ϭ 2; 10%; Fig. 2 ). Statistical analysis re- vealed no significant difference between groups (P ϭ 0.159; Table II) . Evaluation of the NF-B LI according to the level of MMP-9 expression in epithelial cells lining the cysts showed a mean index of 8.9% (range 0.2%-44.2%) for cysts scored as 1. On the other hand, cysts scored as 2 presented a mean LI of 10.9% (range 0.2%-39.2%). Nonparametric Mann-Whitney test revealed no significant difference between groups (P ϭ .282). Similarly, separate analysis of OKCs, DCs, and RCs showed no significant differences in NF-B LI according to the level of MMP-9 expression in the epithelial lining (P ϭ .313; P ϭ .650; and P ϭ .721; respectively).
Analysis of the expression of MMP-9 in the capsule of the lesions studied showed a relatively similar distribution of score 1 (n ϭ 8; 40%) and score 2 (n ϭ 9; 45%) in OKCs. Score 0 was observed in 15% of cases (n ϭ 3). In contrast, in DCs there was a similar distribution of score 0 (n ϭ 8; 40%) and score 1 (n ϭ 9; 45%), whereas score 2 was observed in 15% of cases (n ϭ 3). In RCs, there was a predominance of score 2 (n ϭ 11; 55%), followed by score 3 (n ϭ 5; 25%) and score 0 (n ϭ 4; 20%; Fig. 2 ). Statistical analysis showed no significant difference between groups (P ϭ .100; Table II) .
Analysis of the expression of MMP-9 in vessels of the odontogenic cysts showed a predominance of score 2 (n ϭ 16; 80%), followed by score 1 (n ϭ 4; 20%), in OKCs. DCs presented a higher percentage of cases classified as score 1 (n ϭ 15; 75%), followed by score 2 (n ϭ 4; 20%) and score 0 (n ϭ 1; 5%). In RCs, there was a similar distribution of cases scored as 1 (n ϭ 9; 45%) and 2 (n ϭ 10; 50%). Only 1 case (5%) was classified as score 0. The 2 test revealed a significant difference between groups (P ϭ .002; Table II) .
Regarding angiogenesis, the highest mean MVC was obtained for RCs (16.9, range 2.0-44.0), followed by DCs (12.1, range 0.0-48.0) and OKCs (10.0, range 1.7-39.0; Fig. 3) . However, the Kruskal-Wallis test revealed no significant difference in MVC between groups (P ϭ .163; Table I ).
Analysis of MVC according to the level of expression of MMP-9 in endothelial cells revealed a mean count of 13.9 vessels (median 15.4, range 0.0-48.0) for cysts with score 0/1, whereas cysts scored as 2 had a mean count of 12.2 vessels (median of 8.16, range 1.7-39.0). There was no significant difference between groups (P ϭ .689; nonparametric Mann-Whitney test). Similarly, separate analysis of OKCs, DCs, and RCs showed no significant differences in MVC according to the level of MMP-9 expression in endothelial cells (P ϭ .965; P ϭ .965; P ϭ .676; respectively).
DISCUSSION
DCs are the most common developmental cysts. In the past, it was believed that the epithelial lining of these cysts has a higher proliferative potential than the epithelial lining of inflammatory cysts, such as RC. 7 OKCs are one of the most frequent odontogenic lesions and require special attention because of their aggressive biologic behavior and tendency toward recurrence. 21, 22 Studies have demonstrated a high proliferative activity of these lesions and the expression of proteins associated with the inhibition of apoptosis, 23, 24 in addition to the observation of allelic losses, especially in the P16, P53, PTCH, MCC, TSLC1, LTAS2, and FHIT genes. 25 In view of OKC's aggressive biologic behavior, studies have tried to identify the molecular basis underlying the distinct behavior of OKCs compared with other odontogenic cysts. The present study evaluated the immunohistochemical expression of NF-B, MMP-9, and CD105 in DCs, RCs, and OKCs and compared the expression of these markers between lesions.
In quiescent cells, the nuclear transcription factor NF-B is sequestered in the cytoplasm by IB proteins. 26 Its activation by cytokines requires the phosphorylation and degradation of the cytoplasmic inhibitor IB␣. 27 Once activated, NF-B is translocated to the nucleus, where it induces the expression of a set of target genes, including those involved in tumor metastasis, cell-cycle regulatory genes, and growth factor genes, in addition to regulating MMP genes, such as MMP-9.
8 Therefore, activated NF-B plays an important role in cell differentiation, proliferation, and apoptosis in response to a variety of physiologic and pathologic stimuli. Studies have shown that NF-B activity can be detected in cells of different tumors, but little is known about its role in odontogenic lesions. 10 In a comparative study of ameloblastomas and tooth germs, Kumamoto and Ooya 28 observed scarce nuclear NF-B staining in both tumors and normal odontogenic epithelium. Similarly, Gong et al., 10 analyzing NF-B staining in calcifying odontogenic cysts and classic ameloblastomas, found scarce nuclear staining (Ͻ1%) in the 2 groups. Despite these findings, an association between higher NF-B expression and greater aggressiveness has been demonstrated for different malignant tumors. 27, 29, 30 In the present study, a significant difference in the NF-B LI was observed among OKCs, DCs, and RCs, with a higher mean index (21.1%) in OKCs. Therefore, the higher nuclear expression of this factor in OKCs might be related to the greater aggressiveness of those tumors compared with DCs and RCs.
NF-B regulates the expression of a large number of proinflammatory cytokines, such as tumor necrosis factor ␣, interleukin-1, and interleukin-6, as well as MMPs. 31 MMPs are important proteases that cause structural and functional changes in extracellular matrix components. Under physiologic conditions, MMPs are poorly expressed in tissues. However, overexpression of these proteins is observed under pathologic conditions, which is the result of an imbalance between the activity of MMPs and their inhibitors (TIMPs). 12 Among MMPs, gelatinase B (MMP-9) plays an important role in angiogenesis as well as in tumor invasion and metastasis, mainly because of its capacity to cleave collagen IV present in the basement membrane. 32 Despite the small number of studies involving odontogenic lesions, the expression of MMP-9 was demonstrated in ameloblastoma, calcifying cystic odontogenic tumor, dentinogenic ghost cell tumor, odontogenic ghost cell carcinoma, OKC, DC, and RC. 10, 12, 16 Kubota et al., 33 investigating whether the latent (92 kDa) or active (83 kDa) form of MMP-9 is present in fluids of OKCs, DCs, and RCs, observed the presence of the active form in 75% of OKCs and Table II . Distribution of cases of radicular cysts, dentigerous cysts, and odontogenic keratocysts according to the percentage of cells stained by MMP-9 in epithelium, fibrous capsule, and blood vessels, n (%) 34 MMP activity analyzed by zymography showed a significant correlation with immunohistochemical staining.
In an attempt to elucidate the molecular basis underlying the more aggressive biologic behavior of OKCs compared with DCs and RCs and in view of the higher nuclear NF-B staining in OKCs observed in the present study, we analyzed NF-B LIs according to the expression of MMP-9 in the epithelial cells lining these lesions. Despite the lack of a significant difference, MMP-9 expression by epithelial cells tended to be higher in OKCs compared with DCs and RCs. This finding suggests a possible role of NF-B as a transcription factor of this metalloproteinase, because, like MMP-9 expression, the activated factor was detected in the epithelium of most OKCs. This fact has also been reported in the literature by dell'Agli et al., 8 who suggested that NF-B acts as a transcription factor, and by Garg and Aggarwal, 9 who reported a role of this factor as a regulator of MMP-9 gene expression.
Regarding the expression of MMP-9 in the fibrous capsule of the odontogenic lesions studied, the tendency toward higher expression of this protein in the fibrous capsule of OKCs compared with DCs and RCs observed in the present study agrees with the findings reported by Silveira et al. 16 Kumamoto et al., 35 analyzing the expression of MMP-9 in ameloblastomas, also detected strong reactivity to this metalloproteinase in the stroma of these tumors, suggesting that an increased production of this protein by neoplastic cells is related to the neoplastic transformation of odontogenic tissues and aggressiveness of these tumors. Taken together, these findings and the results of the present study suggest that the higher expression of MMP-9 in the mesenchymal component of OKCs contributes to the more aggressive behavior of these tumors compared with inflammatory cysts and DCs by promoting the degradation of extracellular matrix. In contrast, expression of MMP-9 in epithelial cells might be responsible for the degradation of the basement membrane.
Different methods are available for the evaluation of angiogenesis in biologic material, including MVC and the determination of microvessel density and volume. [36] [37] [38] Among these methods, MVC is an easy technique that has prognostic relevance in different tumors. 38, 39 One widely used angiogenic marker is endoglin, or CD105, which was originally identified as a human endothelial marker although subsequent studies demonstrated that this cell surface antigen is also expressed by macrophages, erythrocyte precursors, and stromal cells. 40 Endoglin binds to various transforming growth factor ␤ isoforms and exhibits high affinity for human endothelial cells. This protein plays an important role in angiogenesis and is considered to be a powerful marker of neovascularization. 41 In the present study, mean MVC was higher in RCs than in DCs and OKCs (P ϭ .163). Despite the lack of reports using MVC for the evaluation of angiogenesis in these lesions, in a comparative study of microvessel density between OKCs and RCs, Tete et al. 42 observed higher vascularization in RCs. The higher mean MVC in RCs seen in the present study might be related to the presence of an exuberant inflammatory infiltrate in these lesions, because, according to Graziani et al. 43 and Nonaka et al., 6 inflammatory cells can exert angiogenic activity in these cysts.
In the present study, MVC was higher in DCs than in OKCs. These results differ from those reported by Alaeddini et al. 4 who observed higher microvessel density in OKCs compared with DCs. One possible explanation for this difference is the fact that in the latter study microvessel density was evaluated based on immunoreactivity to the anti-CD34 antibody, whereas in the present investigation CD105 immunostaining was used for microvessel quantification.
In addition, analysis of MVC according to the expression of MMP-9 in endothelial cells revealed no significant difference between OKCs, DCs, and RCs. In fact, the role of MMP-9 in the development of the lesions studied might be associated with the regulation of other factors unrelated to angiogenesis, such as factors involved in cell proliferation and migration, apoptosis, and immune and inflammatory responses. 44 In conclusion, the present results suggest that the more aggressive biologic behavior of OKCs compared with RCs and DCs is related to the higher expression of MMP-9 and NF-B in these lesions. In addition, differences in the biologic behavior of the lesions studied do not seem to be associated with the angiogenic index.
